Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

The Biggest Trade Secret Rulings Of 2026: A Midyear Report No Photo Available

The Federal Circuit issued two of the year's most consequential trade secret rulings within days of each other, wiping out Insulet's v... (more story)

Circuit-By-Circuit Guide To The US Supreme Court's Term No Photo Available

Federal appeals courts had wide-ranging successes and struggles during the U.S. Supreme Court's recently completed term: One had its b... (more story)

Healthcare Attys Become 'Producers' To Seal Provider Deals No Photo Available

Attorneys putting together big provider transactions today say they see a growing need for what they call a producer approach to their... (more story)